SPEAKERS
of the Insights in Hematology

2021 Conference


Horia Bumbea, M.D. Ph.D.

Dr. Horia Bumbea, is Associate Professor at University of Medicine and Pharmacy Carol Davila at the Department of Hematology in the Emergency University Hospital, Bucharest. He is coordinator of Flowcytometry Lab, and the diagnosis of acute leukemia national program in this center, coordinator of Blood and Marrow Transplant Unit and Center of Expertise in Hematological Rare Disorders, affiliated to ECNM since 2017. Member of European Hematology Association (EHA); European Society of Clinical Cell Analysis (ESCCA); American Society of Hematology (ASH), European LeukemiaNet (ELN), European Research Initiative on CLL (ERIC), member in board of Romanian Society of Hematology and working group of CLL and hematological diagnosis, president of Romanian Association of Cytometry.
Areas of research: clinical studies in hematological malignancies, flowcytometry (immunophenotyping), cellular and molecular diagnostic, targeted immunotherapy, personalized medicine, bone marrow transplant, rare diseases. The experience was accumulated as project manager or responsible partner during the national research projects and clinical trials.

Alina Tănase, M.D.

Dr. Alina Tanase is head of the Bone marrow Transplantation Unit at the Fundeni Clinical Institute with expertise in hematology, pediatrics and clinical immunolgy. She was the manager of a postdoctoral research scholarship in a POSDRU 2010-2013 grant entitled “Supporting research by forming highly trained specialists during postdoctoral research”. Dr. Alina Tanase has published several internationally peer-reviewed papers in important journals such as Leukemia, the Lancet Oncology or Transplantation Proceedings.

Ciprian Tomuleasa, M.D.

Dr. Ciprian Tomuleasa is the Congress Director of Insights in Hematology Conference. Dr. Tomuleasa is a young physician-scientiest that is currently affiliated with the Ion Chiricuță Clinical Cancer Center and Iuliu Hațieganu University of Medicine and Pharmacy Cluj Napoca, Romania. He did part of his training as a postdoctoral fellow at the Johns Hopkins University in the department of medicine, division of GI, and his transplant rotations with Dr. Ciurea at the University of Texas MD Anderson Cancer Center. His current research regards the molecular mechanism of haematological malignancies and the translation of his knowledge in the clinical setting. He published 85 papers, was cited 600 times and has a Hirsch index of 16.

Daniela Sauma, Ph.D.

Daniela Sauma has a degree in biochemistry from the University of Chile and obtained her Ph.D. at the Faculty of Sciences of the same University. Her thesis was pioneer work in the field of Immunology by studying the role of Notch signaling pathway in T-cell differentiation. She completed her postdoctoral studies at Fundacion Ciencia & Vida and in 2013 she joined the Department of Biology of the Faculty of Sciences of the University of Chile. Dr. Sauma has directed several undergraduate students and has received several national awards and distinctions including the “For Women in Science Award” of L’ Oreal , UNESCO and CONICYT and Dr. Hermann Niemeyer medal awarded by the Chilean Society for Biochemistry. In 2009 she was recognized as one of the “100 young leaders ” in El Mercurio. Her current research focuses on the study of purinergic signaling in T-cell differentiation.

Gabriel Ghiaur, M.D., Ph.D.

Dr. Ghiaur, a member of the Johns Hopkins Kimmel Cancer Center, is a physician-scientist whose primary interest is normal and malignant hematopoiesis, especially the role of the microenvironment in stem cell biology. His research has translational potential in stem cell therapeutics, as well as acute leukemia.

Jo Caers, M.D., Ph.D.

Professor of Hematology
Laboratory of Hematology, University of Liege, Liege, Belgium

Ólafur E. Sigurjónsson, M.Sc., Ph.D.

Olafur finished a B.Sc. degree in molecular biology from the faculty of biology, University of Iceland in 1998 and a M.Sc. degree in medical science from the faculty of medicine, University of Iceland in 2001. The topic of his M.Sc. thesis was “Megakaryocyte development in vitro: differentiation, ploidy and apoptosis”. In this thesis, he explored differentiation of megakaryocytes and platelet precursors from heamtopoietic stem cells. In 2002, Olafur started a PhD at the Institute of Immunology and the department of Physiology at the University of Oslo and graduate in 2006. The thesis was titled, “The differentiation potential of somatic stem cells”. In this thesis, Oalfur continued working with hematopoeitic stem cells, further analyzing megakaryocyte development and neural differentiation. Describing new potential stem cells genes (in collaboration with Kristbjörn Orri Guðmundsson and Jonathan R. Keller) as well as describing a potential phenotype for isolation of mesenchymal stem cells from adipose tissue. For this thesis, he was awarded the ” H.M. Kongens gullmedalje” by king Haakon V of Norway in 2007. In 2006 Olafur took over as manager and Principal Investigator at the laboratory of stem cell research and cellular therapy, at the Blood Bank. In 2008 Olafur became assistant professor at the Biomedical Engineering department, School of Science and Engineering, Reykjavik University.

Delia Dima, M.D.

Dr. Delia Dima is a senior hematologist at the Ion Chiricuta Oncology Institute and will talk about the clinical nursing approach for the haemophilia patient, as a symposium organized on behalf of the Romanian Society of Hematology for Romania 3 Project – Strenghten haemophilia care in the north and establish a national registry in Romania, grant awarded for 2020 – 2021 by the Novo Nordisk Haemophilia Foundation.

Vernon Louw, M.D., Ph.D.

Dr. Vernon Louw is a professor, Head of the Department of Internal Medicine and Clinical Haematologist at the School of Medicine, Faculty of Health Sciences, University of the Free State, South Africa, Chair and Head Clinical Haematology, Department of Medicine, University of Cape Town and a clinical Haematologist in Panorama Mediclinic.
After completing his medical degree (MBChB) and M.Med (Internal Medicine) at the University of Stellenbosch (both cum laude), he spent three years at the Katholieke Universiteit Leuven in Belgium in Clinical Haematology. In 2011, he obtained his Ph.D. in Health Professions Education at the University of the Free State, studying postgraduate education in transfusion medicine. He is the recipient of numerous awards, including the University of Stellenbosch medal for the best postgraduate student of all health-related disciplines in the year 2000. His research focus is in transfusion medicine, education, and HIV-related haematological disease. He has published more than 90 papers in national and international medical journals with more than 250 poster and oral presentations at national, and international meetings. He is a member of, inter alia, the American Society of Hematology (ASH), the International Society of Hematology (ISH), the European Haematology Association (EHA), and the African Society for Blood Transfusion (AfSBT). He serves on the editorial board or as reviewer for a number of national and international medical journals, and is a member of and chairs a number of national and international advisory boards. He has served on the scientific and organizing committees of a number of national and international conferences. His vision is to develop online learning platforms for haematology and transfusion medicine that could benefit healthcare in Africa. Together with his team, he developed the first Anglophone Postgraduate Diploma and Master’s Degree Programmes in Transfusion Medicine in Africa.

Victor Greiff, M.D., Ph. D

Dr. Greiff started his research group in 2018 at the University of Oslo (UiO), Department of Immunology. The group develops computational and experimental tools to decipher, read, predict and re-engineer antibody and T-cell repertoires with the aim to develop fundamentally novel immunodiagnostics, vaccines and immunotherapeutics. He uses his time away from science to catch up on current immunology topics, technology developments, and state of the art algorithms – wait a minute, that’s just more science!

Dominik Wolf, M.D.

Dominik Wolf studied medicine at the University of Erlangen-Nuremberg and completed his doctorate “summa cum laude”. After his training as an internist at the Medical University of Innsbruck, where he habilitated in internal medicine in 2008 and the recognition of the additive subject “Hematology and Internal Oncology”, he followed the call of the University Hospital Bonn (UKB) in 2011 to the professorship for tumor immunology and as Deputy Clinic Director of the Medical Clinic 3 for Oncology, Hematology, Immuno-oncology and Rheumatology. There, Wolf established and directed the KMT (bone marrow transplantation) program, the Myeloid Neoplasms Unit, the Clinical Trials Outpatient Clinic, and the Immuno-Oncology (IO) Outpatient Clinic. His research focuses on immune regulation in cancer and transplantation and inflammation in myeloid disease. Clinically, Wolf focuses on immuno-oncology, myeloid neoplasms and stem cell transplantation. Since October 1, 2018, he has been director of the Univ. Clinic for Internal Medicine V, Hematology and Oncology, which was previously established and led for 22 years by Günther Gastl.

Daniel Coriu, M.D., Ph.D.

Romanian College of Physicians

Carlo Croce, M.D., Ph.D.

The Ohio State University, Columbus, Ohio, USA

Amy Dezern, M.D.

Johns Hopkins University, USA

Leo Luznik, M.D.

Johns Hopkins University, USA

Lukasz Gondek, M.D.

Johns Hopkins University, Baltimore, USA

Carmen Escuriola Ettingshausen, M.D.

Ling Peng, Ph.D.

Equipe Labellisée Ligue Contre le Cancer, Centre Interdisciplinaire de Nanoscience de Marseille
Aix-Marseille University, Marseille, France

Mihnea Zdrenghea, M.D., Ph.D.

Dr. Mihnea Zdrenghea is one of the most appreciated hematologists in Romania, with a significant backround in both medical and clinical research. Dr. Zdrenghea has completed his PhD in tumor immunology and is the author of more than 20 scientific papers, as well as an author to 6 books. He is an attending physician in hematology at the Oncology Institute “Prof. Dr. Ion Chiricuta” in Cluj-Napoca. The skills and qualification of him as a department leader reflect on the entire research team and it is apparent the the collaboration with partner investigators can be accomplished. The publications and extensive experience in cancer biology research, proven by his ongoing projects and previous results, recommend Dr. Zdrenghea for capably managing a professional team of researchers that have the potential of bringing new innovative results

Mihaela-Andreescu-hematolog-protocol-anticoagulante

Mihaela Andreescu, M.D.

Screenshot 2021-09-14 at 20.59.14

Stefan Lethagen M.D.

Foto Minodora Onisai

Dr Minodora-Cezarina Onisâi

Dr Minodora-Cezarina Onisâi is senior physician in clinical hematology and lecturer at University of Medicine and Pharmacy Carol Davila Bucharest. She a member of the Romanian Hematology Society and the Romanian Flowcitometry Society. She has been actively involved in five national research grants and multiple international clinical studies during her career, and she has attended training courses both in Romania and abroad. She has coauthored three monographies, published over 75 in extenso scientific articles and won a number of awards for her papers that were presented in national and international medical events.

Foto-2-Magic-684x1024

Dr. Sorina Bădeliță

Dr. Sorina Bădeliță, Senior Specialist in Hematology, Fundeni Clinical Institute, Hematology and Bone Marrow Transplantation Center.
She is Member of European Hematology Association, since 2007, Member of Romanian Hematology Association, since 2005 and member of International Myeloma Society.
Dr Badelita has been main investigator in numerous multicenter clinical trials with indications in multiple myeloma and amyloidosis.
Her clinical and research focus has been treatments of multiple myeloma patients and other pathologies of monoclonal proteins.

Gianluca Gaidano, M.D., Ph.D.

Gianluca Gaidano is Professor of Hematology at the Medical School of the University of Eastern Piedmont (Universita’ del Piemonte Orientale), Novara, Italy. He is also the Director of the Division of Hematology of the Academic Hospital “Maggiore della Carità di Novara”, University Vice-Rector for International Affairs, and the Director of the Medical Biotechnologies Master Degree Program at the University of Eastern Piedmont. He is a member of EHA, ASH, ASCO, AACR, Henry Kunkel Society, SIE and SIES, and a former President of the Italian Society of Experimental Hematology. He has been a board member of EHA for years 2015-2019, and is a current board member of the Italian Lymphoma Foundation (FIL), of the Italian Society of Hematology, and of the GIMEMA Working Party on chronic lymphoproliferative disorders. He started his medical career at the University of Turin, where he received his M.D. (1987) and Ph.D (1991), and became a specialist in Internal Medicine and Hematology. From 1990 to 1994, he was at Columbia University (Dalla-Favera’s lab), New York, where he trained in molecular hematology. His research interests relate mainly to the clinical implications of the molecular genetics of lymphoid malignancies, with a particular focus on the development of new diagnostic and prognostic markers as well as targeted treatments for B-cell lymphoma and chronic lymphocytic leukemia (CLL). Using a genomic approach, his research group recently identified several novel genetic alterations predicting poor outcome in CLL. Other fields of interest concern hematologic neoplasias developing in immunodeficient patients. He has contributed to several hematology and oncology textbooks, including the DeVita, Hoffman, and Magrath.